Loading publications…
The last 5 uploaded publications
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Phrutsamon Wongnak, William HK Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M. Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mayfong Mayxay, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Elizabeth A. Ashley, Arjen M. Dondorp, Nicholas Day, Mauro Martins Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White, James A Watson (2024). Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV). The Lancet Infectious Diseases, 24(9), pp. 953-963, DOI: 10.1016/s1473-3099(24)00183-x.
Article144 days agoAntiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Podjanee Jittamala, Simon Boyd, William HK Schilling, James A Watson, Thundon Ngamprasertchai, Tanaya Siripoon, Viravarn Luvira, Elizabeth M. Batty, Phrutsamon Wongnak, Lísia Esper, Pedro J. Almeida, Cintia Cruz, Fernando Roque Ascenção, Renato Santana Aguiar, Najia Karim Ghanchi, James J. Callery, Shivani Singh, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Wanassanan Madmanee, Kanokon Suwannasin, Amornrat Promsongsil, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Walter Taylor, Farah Naz Qamar, Abdul Momin Kazi, Madiha Beg, Danoy Chommanam, Sisouphanh Vidhamaly, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas P. J. Day, Mauro Martins Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White (2025). Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). EClinicalMedicine, 80, pp. 103036-103036, DOI: 10.1016/j.eclinm.2024.103036.
Article144 days agoCharacterising viral clearance kinetics in acute influenza
Phrutsamon Wongnak, Timothy Seers, Podjanee Jittamala, Mallika Imwong, William HK Schilling, James A Watson, Sir Nicholas White (2025). Characterising viral clearance kinetics in acute influenza. medRxiv (Cold Spring Harbor Laboratory), DOI: 10.1101/2025.03.07.25323547.
Preprint144 days agoA comparison of national seasonal influenza treatment guidelines across the Asia Pacific region
Ellen M. Beer, Simon Boyd, Phrutsamon Wongnak, Thundon Ngamprasertchai, Sir Nicholas White (2025). A comparison of national seasonal influenza treatment guidelines across the Asia Pacific region. PLOS Global Public Health, 5(4), pp. e0004468-e0004468, DOI: 10.1371/journal.pgph.0004468.
Article79 days agoAntiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Podjanee Jittamala, Simon Boyd, William HK Schilling, James A Watson, Thundon Ngamprasertchai, Tanaya Siripoon, Viravarn Luvira, Elizabeth M. Batty, Phrutsamon Wongnak, Lísia Esper, Pedro J Almeida, Cintia Cruz, Fernando Roque Ascenção, Renato Santana Aguiar, Najia Karim Ghanchi, James J. Callery, Shivani Singh, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Wanassanan Madmanee, Kanokon Suwannasin, Amornrat Promsongsil, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, Walter RJ Taylor, Farah Naz Qamar, Abdul Momin Kazi, Madiha Beg, Danoy Chommanam, Sisouphanh Vidhamaly, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas Day, Mauro Martins Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Sir Nicholas White (2024). Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). medRxiv (Cold Spring Harbor Laboratory), DOI: 10.1101/2024.01.16.24301337.
Preprint144 days ago